Videos Archives - 91ÌÒÉ«ÊÓƵ /category/videos/ microbiota gut Thu, 18 Dec 2025 23:21:31 +0000 en-US hourly 1 https://wordpress.org/?v=6.8.3 /wp-content/uploads/2018/10/cropped-logo-maat-pharma-author-32x32.png Videos Archives - 91ÌÒÉ«ÊÓƵ /category/videos/ 32 32 Replay: KOL insights and MaaT013 Data from ASH 2024 Meeting /maat-pharma-key-opinion-leader-discussion-ash-2024/ Wed, 18 Dec 2024 13:14:50 +0000 /?p=13795 • December 17, 2024 – 91ÌÒÉ«ÊÓƵ - Key Opinion Leader Discussion - ASH 2024

The post Replay: KOL insights and MaaT013 Data from ASH 2024 Meeting appeared first on 91ÌÒÉ«ÊÓƵ.

]]> Replay of the virtual KOL event featuring Prof. Mohamad Mohty, MD, PhD (Saint-Antoine Hospital – AP-HP) and Dr. Monzr M. Al Malki, MD (City of Hope) where they discussed:Ìý

  • Unmet medical needs in acute Graft-versus-Host Disease,Ìý
  • The latest data on MaaT013 from the Early Access Program, as presented at the 2024 ASH Annual Meeting,
  • The potential of microbiome immunomodulation in their clinical practice.

Dowload the presentation here.

Find below the video summary:

00:00 to 8:40 : Introduction by Hervé Affagard, CEO and co-founder of 91ÌÒÉ«ÊÓƵ

8:41 to 14:55 : Unmet need for MaaT013 in GvHD in Europe and in the US with Dr. Monzr M. Al Malki M.D

14:56 to 26:00 : Results from the Early Access Program in Europe with Pr Mohamad Mohty, M.D

26:01 to 29:45 : Upcomming milestones for 91ÌÒÉ«ÊÓƵ with Hervé Affagard

29:46 to 56:46 : Q&A session, with Pr Mohamad Mohty, M.D, Dr. Monzr M. Al Malki M.D, Hervé Affagard, and Gianfranco Pittari M.D. PhD, Chief Medical Officer of 91ÌÒÉ«ÊÓƵ

The post Replay: KOL insights and MaaT013 Data from ASH 2024 Meeting appeared first on 91ÌÒÉ«ÊÓƵ.

]]> R&D Day 2022 replay /rd-day-2022-replay/ Wed, 08 Jun 2022 13:33:45 +0000 /?p=7890 On June 7th, 2022, 91ÌÒÉ«ÊÓƵ hosted its virtual R&D Day to share the latest clinical results of our key assets, as well as our R&D strategy to position 91ÌÒÉ«ÊÓƵ as a leader of microbiome therapies. This 2-hour event also included presentations from world-renowned experts in oncology and in the microbiome fields including: Dr. Joël Doré – Research Director, INRAE and Scientific Advisor at 91ÌÒÉ«ÊÓƵ, France Pr. Ernst Holler, M.D – Senior Professor on Clinical and Experimental Allo-HSCT, Dept of Internal Medicine 3, University Hospital Center Regensburg, Germany Pr. Florent Malard, M.D – Professor of Hematology, Saint Antoine Hospital (APHP) and Associate Professor, Sorbonne University Pr. Mohamad Mohty, M.D – Professor, Sorbonne University and Head of the Clinical Hematology and Cellular Department, Saint-Antoine Hospital (AP-HP), France Pr. Hassane Zarour, M.D – Professor of Medicine, Immunology and Dermatology, University of Pittsburgh, USA   Download the presentation Replay video conferenceÌý    

The post R&D Day 2022 replay appeared first on 91ÌÒÉ«ÊÓƵ.

]]> On June 7th, 2022, 91ÌÒÉ«ÊÓƵ hosted its virtual R&D Day to share the latest clinical results of our key assets, as well as our R&D strategy to position 91ÌÒÉ«ÊÓƵ as a leader of microbiome therapies. This 2-hour event also included presentations from world-renowned experts in oncology and in the microbiome fields including:

  • Dr. Joël Doré – Research Director, INRAE and Scientific Advisor at 91ÌÒÉ«ÊÓƵ, France
  • Pr. Ernst Holler, M.D – Senior Professor on Clinical and Experimental Allo-HSCT, Dept of Internal Medicine 3, University Hospital Center Regensburg, Germany
  • Pr. Florent Malard, M.D – Professor of Hematology, Saint Antoine Hospital (APHP) and Associate Professor, Sorbonne University
  • Pr. Mohamad Mohty, M.D – Professor, Sorbonne University and Head of the Clinical Hematology and Cellular Department, Saint-Antoine Hospital (AP-HP), France
  • Pr. Hassane Zarour, M.D – Professor of Medicine, Immunology and Dermatology, University of Pittsburgh, USA

 

Download the presentation

Ìý

 

 

The post R&D Day 2022 replay appeared first on 91ÌÒÉ«ÊÓƵ.

]]> H.C Wainwright Bioconnect 2022 conference replay /h-c-wainwright-bioconnect-2022-conference-replay/ Fri, 14 Jan 2022 13:27:53 +0000 /?p=6371 Hervé Affagard, CEO and co-founder of 91ÌÒÉ«ÊÓƵ, presented the company at the H.C. Wainwright Bioconnect Virtual Conference held January 10-13, 2022. Replay the presentation

The post H.C Wainwright Bioconnect 2022 conference replay appeared first on 91ÌÒÉ«ÊÓƵ.

]]> Hervé Affagard, CEO and co-founder of 91ÌÒÉ«ÊÓƵ, presented the company at the H.C. Wainwright Bioconnect Virtual Conference held January 10-13, 2022.

The post H.C Wainwright Bioconnect 2022 conference replay appeared first on 91ÌÒÉ«ÊÓƵ.

]]> Investors Webcast – 12/13/21 – Corporate Update /investors-webcast-12-13-21/ Fri, 17 Dec 2021 17:41:05 +0000 /?p=6234 Webcast, December 13, 2021 Corporate Update: positive results for MaaT013 from Phase 2 clinical trial and early access program Download the presentation Transcript of the webcast Replay video conference 

The post Investors Webcast – 12/13/21 – Corporate Update appeared first on 91ÌÒÉ«ÊÓƵ.

]]> Webcast, December 13, 2021

Corporate Update: positive results for MaaT013 from Phase 2 clinical trial and early access program

Download the presentation

Transcript of the webcast

The post Investors Webcast – 12/13/21 – Corporate Update appeared first on 91ÌÒÉ«ÊÓƵ.

]]> IABS Bioaster – FMT WEBINAR /iabs-bioaster-fmt-webinar/ Wed, 02 Jun 2021 09:04:57 +0000 //?p=2634 Watch the replay of the presentation by Our CEO Herve Affagard, MBA, Eng., during the International Alliance for Biological Standardization – IABSÌý&ÌýBIOASTER Webinar entitled « The Evolution of FMT – From Early Clinical to Standardized Treatments » which took place on May 21, 2021.

The post IABS Bioaster – FMT WEBINAR appeared first on 91ÌÒÉ«ÊÓƵ.

]]> Watch the replay of the presentation by Our CEO , during the Ìý&Ìý Webinar entitled « The Evolution of FMT – From Early Clinical to Standardized Treatments » which took place on May 21, 2021.

The post IABS Bioaster – FMT WEBINAR appeared first on 91ÌÒÉ«ÊÓƵ.

]]> EY : Prix de l’Entrepreneur de l’Année /ey-prix-de-lentrepreneur-de-lannee/ Wed, 05 May 2021 08:04:46 +0000 //?p=2590 Découvrez ci-dessous l’intervention de notre CEOÌýHerve Affagard, MBA, Eng. pour le Prix de l’Entrepreneur de l’Année de EY. L’équipe d’EY est venue nous rendre visite au mois de février afin de filmer cette interview dans nos nouveaux locaux.  

The post EY : Prix de l’Entrepreneur de l’Année appeared first on 91ÌÒÉ«ÊÓƵ.

]]> Découvrez ci-dessous l’intervention de notre CEOÌý pour le Prix de l’Entrepreneur de l’Année de EY. L’équipe d’EY est venue nous rendre visite au mois de février afin de filmer cette interview dans nos nouveaux locaux.

 

The post EY : Prix de l’Entrepreneur de l’Année appeared first on 91ÌÒÉ«ÊÓƵ.

]]> Hybridays 2021: Savita BERNAL, Chief Business Officer at 91ÌÒÉ«ÊÓƵ /hybridays-2021-savita-bernal-chief-business-officer-at-maatpharma/ Wed, 28 Apr 2021 14:19:38 +0000 //?p=2581 Our Chief Business OfficerÌýSavita Bernal attended HYBRID 2021, on March 16th, an event focused this year on Immunology and Inflammatory Disorders. Savita shared with the audience a presentation entitled « Diversity MattersÌý:Ìý 91ÌÒÉ«ÊÓƵ’s Microbiome Ecosystem Therapies in Graft-vs-Host-Disease and Oncology». See the full video down below.

The post Hybridays 2021: Savita BERNAL, Chief Business Officer at 91ÌÒÉ«ÊÓƵ appeared first on 91ÌÒÉ«ÊÓƵ.

]]> Our Chief Business OfficerÌý attended , on March 16th, an event focused this year on Immunology and Inflammatory Disorders. Savita shared with the audience a presentation entitled « Ìý:Ìý 91ÌÒÉ«ÊÓƵ’s Microbiome Ecosystem Therapies in Graft-vs-Host-Disease and Oncology».

See the full video down below.

The post Hybridays 2021: Savita BERNAL, Chief Business Officer at 91ÌÒÉ«ÊÓƵ appeared first on 91ÌÒÉ«ÊÓƵ.

]]>